When.com Web Search

  1. Ads

    related to: prasco albuterol sulfate hfa price

Search results

  1. Results From The WOW.Com Content Network
  2. Prasco Laboratories - Wikipedia

    en.wikipedia.org/wiki/Prasco_Laboratories

    Prasco is a pharmaceutical company headquartered in Cincinnati, Ohio, and founded in 2002 by E. Thomas Arington, former Chairman and CEO of Duramed Pharmaceuticals ...

  3. Salbutamol - Wikipedia

    en.wikipedia.org/wiki/Salbutamol

    Salbutamol is the international nonproprietary name (INN) while albuterol is the United States Adopted Name (USAN). [36] The drug is usually manufactured and distributed as the sulfate salt (salbutamol sulfate). It was first sold by Allen & Hanburys (UK) under the brand name Ventolin, and has been used for the treatment of asthma ever since. [37]

  4. ProAir® HFA (albuterol sulfate) with Dose Counter Now ...

    www.aol.com/news/2013-01-03-proair-hfa-albuterol...

    ProAir ® HFA (albuterol sulfate) with Dose Counter Now Available to Patients NORTH WALES, Pa.--(BUSINESS WIRE)-- Teva Respiratory announced today the availability of ProAir® HFA with dose ...

  5. Ipratropium bromide/salbutamol - Wikipedia

    en.wikipedia.org/wiki/Ipratropium_bromide/salbutamol

    Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary disease (COPD). [1] [4] [5] It contains ipratropium (an anticholinergic) and salbutamol (albuterol, a β 2-adrenergic agonist).

  6. Salbutamol/budesonide - Wikipedia

    en.wikipedia.org/wiki/Salbutamol/budesonide

    Salbutamol/budesonide, sold under the brand name Airsupra, is a fixed-dose combination medication for the treatment of bronchoconstriction and asthma. [1] [2] It is a combination of salbutamol sulfate (albuterol sulfate), a short-acting beta2-adrenergic agonist, and budesonide, an inhaled corticosteroid.

  7. Levosalbutamol - Wikipedia

    en.wikipedia.org/wiki/Levosalbutamol

    A 2013 systematic review of the drug's use as a treatment for acute asthma found that it "was not superior to albuterol regarding efficacy and safety in subjects with acute asthma." The review concluded: "We suggest that levalbuterol should not be used over albuterol for acute asthma." [2] Levalbuterol is notably more costly. [4] [5]